Public-health officials are enthusiastic about the new, single-shot COVID-19 vaccine from Johnson & Johnson, despite its having a somewhat lower efficacy at preventing symptomatic illness than other available options. Although clinical-trial data peg that rate at 72 percent in the United States, compared with 94 and 95 percent for the Moderna and Pfizer-BioNTech vaccines, many experts say we shouldn’t fixate on those numbers.
The Differences Between the Vaccines Matter
News March 11, 2021 | CanadaOnlineHealth
For inquiries about prescription medications, contact our team at CanadaOnlineHealth by calling 1-800-399-DRUG (3784) for assistance from our patient representatives or a licensed Canadian pharmacist.
This article provides medical information to help understand a condition or treatment plan but is not a diagnosis or treatment recommendation. Contact your doctor if you have concerns or symptoms. In case of emergency, call 911.
Recent Posts
Newsletter
Join our email list to receive our newsletter with special offers, exclusive discounts, and timely product information
Subscribe and Save
We respect your email privacy.
